Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population

ObjectiveThis study aimed to identify the potential urine biomarkers of vascular dementia (VD) and unravel the disease-associated mechanisms by applying Liquid chromatography tandem-mass spectrometry (LC–MS/MS).MethodsLC–MS/MS proteomic analysis was applied to urine samples from 3 groups, including...

Full description

Bibliographic Details
Main Authors: Ruijuan Chen, Yuanjing Yi, Wenbiao Xiao, Bowen Zhong, Le Zhang, Yi Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1070854/full
_version_ 1797943947772821504
author Ruijuan Chen
Ruijuan Chen
Yuanjing Yi
Wenbiao Xiao
Bowen Zhong
Le Zhang
Yi Zeng
author_facet Ruijuan Chen
Ruijuan Chen
Yuanjing Yi
Wenbiao Xiao
Bowen Zhong
Le Zhang
Yi Zeng
author_sort Ruijuan Chen
collection DOAJ
description ObjectiveThis study aimed to identify the potential urine biomarkers of vascular dementia (VD) and unravel the disease-associated mechanisms by applying Liquid chromatography tandem-mass spectrometry (LC–MS/MS).MethodsLC–MS/MS proteomic analysis was applied to urine samples from 3 groups, including 14 patients with VD, 9 patients with AD, and 21 normal controls (NC). By searching the MS data by Proteome Discoverer software, analyzing the protein abundances qualitatively and quantitatively, comparing between groups, combining bioinformatics analysis using Gene Ontology (GO) and pathway crosstalk analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG), and literature searching, the differentially expressed proteins (DEPs) of VD can be comprehensively determined at last and were further quantified by receiver operating characteristic (ROC) curve methods.ResultsThe proteomic findings showed quantitative changes in patients with VD compared to patients with NC and AD groups; among 4,699 identified urine proteins, 939 and 1,147 proteins displayed quantitative changes unique to VD vs. NC and AD, respectively, including 484 overlapped common DEPs. Then, 10 unique proteins named in KEGG database (including PLOD3, SDCBP, SRC, GPRC5B, TSG101/STP22/VPS23, THY1/CD90, PLCD, CDH16, NARS/asnS, AGRN) were confirmed by a ROC curve method.ConclusionOur results suggested that urine proteins enable detection of VD from AD and VC, which may provide an opportunity for intervention.
first_indexed 2024-04-10T20:32:05Z
format Article
id doaj.art-ba7692a33b55454ca81ee9b50738a44b
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-10T20:32:05Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-ba7692a33b55454ca81ee9b50738a44b2023-01-25T06:06:53ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652023-01-011510.3389/fnagi.2023.10708541070854Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese populationRuijuan Chen0Ruijuan Chen1Yuanjing Yi2Wenbiao Xiao3Bowen Zhong4Le Zhang5Yi Zeng6Department of Geriatrics, Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Emergency, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, Hainan, ChinaDepartment of Geriatrics, Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Geriatrics, Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, ChinaDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Geriatrics, Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaObjectiveThis study aimed to identify the potential urine biomarkers of vascular dementia (VD) and unravel the disease-associated mechanisms by applying Liquid chromatography tandem-mass spectrometry (LC–MS/MS).MethodsLC–MS/MS proteomic analysis was applied to urine samples from 3 groups, including 14 patients with VD, 9 patients with AD, and 21 normal controls (NC). By searching the MS data by Proteome Discoverer software, analyzing the protein abundances qualitatively and quantitatively, comparing between groups, combining bioinformatics analysis using Gene Ontology (GO) and pathway crosstalk analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG), and literature searching, the differentially expressed proteins (DEPs) of VD can be comprehensively determined at last and were further quantified by receiver operating characteristic (ROC) curve methods.ResultsThe proteomic findings showed quantitative changes in patients with VD compared to patients with NC and AD groups; among 4,699 identified urine proteins, 939 and 1,147 proteins displayed quantitative changes unique to VD vs. NC and AD, respectively, including 484 overlapped common DEPs. Then, 10 unique proteins named in KEGG database (including PLOD3, SDCBP, SRC, GPRC5B, TSG101/STP22/VPS23, THY1/CD90, PLCD, CDH16, NARS/asnS, AGRN) were confirmed by a ROC curve method.ConclusionOur results suggested that urine proteins enable detection of VD from AD and VC, which may provide an opportunity for intervention.https://www.frontiersin.org/articles/10.3389/fnagi.2023.1070854/fullvascular dementiaAlzheimer’s diseasebiomarkersurineproteomics
spellingShingle Ruijuan Chen
Ruijuan Chen
Yuanjing Yi
Wenbiao Xiao
Bowen Zhong
Le Zhang
Yi Zeng
Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
Frontiers in Aging Neuroscience
vascular dementia
Alzheimer’s disease
biomarkers
urine
proteomics
title Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
title_full Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
title_fullStr Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
title_full_unstemmed Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
title_short Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
title_sort urinary protein biomarkers based on lc ms ms analysis to discriminate vascular dementia from alzheimer s disease in han chinese population
topic vascular dementia
Alzheimer’s disease
biomarkers
urine
proteomics
url https://www.frontiersin.org/articles/10.3389/fnagi.2023.1070854/full
work_keys_str_mv AT ruijuanchen urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation
AT ruijuanchen urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation
AT yuanjingyi urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation
AT wenbiaoxiao urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation
AT bowenzhong urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation
AT lezhang urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation
AT yizeng urinaryproteinbiomarkersbasedonlcmsmsanalysistodiscriminatevasculardementiafromalzheimersdiseaseinhanchinesepopulation